About Orion Therapeutics
Orion Therapeutics is a private company based in Knoxville, Tennessee, incorporated in 2022 in Delaware. It has reported $145,000 raised in two offerings on Form D since December 2022.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 10, 2024 | Sep 25, 2024 | $85,000of $250K target | 4 | $21,250 | OptionsRule 506(b) | Form D ↗ |
| Nov 30, 2022 | Dec 14, 2022 | $60,000of $250K target | 1 | $60,000 | OptionsRule 506(b) | Form D ↗ |
| Total, two offerings | $145,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Orion Therapeutics's Form D filed Sep 25, 2024.
DM
Deidra Mountain
Director
RF
Richard Fisher
Executive officer and director
MM
Michael McCaman
Executive officer and director